Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (HPIMS) / mass spectrometry (MS), has won The Analytical Scientist Innovation Award (TASIA) 2020. TASIAs showcase the technologies driving progress in measurement science. The award recognizes that HPIMS brings the power of state-of-the-art Ion Mobility out of the lab: enabling high resolution and sensitive chemical detection at the point of need...
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability, announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility. VMIC plans to implement the MODA-EM™ Solution as part of its strategy to develop a state-of-the-art manufacturing center due to open in 2021 – fast-tracked to open a year ahead of schedule...
LAUDA DR. R. WOBSER GMBH & CO. KG has once again been declared World Market Leader Champion in the field of "Constant Temperature Equipment and Systems for Precise Temperature Generation". This is the fifth award in a row for LAUDA. The family-owned company has been represented in the World Market Leader Index since the survey first started. The well-respected index has been drawn up under the direction of Prof. Dr. Christoph Müller from the University of St. Gallen since 2015....
Abbott has received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test. IgG antibody testing that gives a quantitative result (measuring the amount of antibodies) provides important insights to people as they recover from COVID-19 and help evaluate a person's immune response to a vaccine. Countries around the world are preparing for the authorisation and the distribution of COVID-19 vaccines....
Illumina, Inc. and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced by many families, with the goal of improving patient outcomes....
A new technology promoted by Telstar provides the interior of the cabinet with a high antimicrobial power and reduces cleaning and maintenance costs. A new photocatalytic treatment based on titanium dioxide has been implemented by Telstar inside their biological safety cabinets, designed to operate with risk 1, 2 and 3 biological agents (viruses and bacteria or infectious material). Zerocoat is the new treatment that provides a self-cleaning surface which breaks down organic matter when the light system is triggered....
ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy. Both companies have a long-standing collaboration and strategic partnership, as arivis has been an important development partner for ZEISS for more than seven years..
Agilent Technologies Inc. has announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North West....
Merck, a leading science and technology company, has announced the broadening of its manufacturing footprint with a combined €40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to customers developing lifesaving therapies, including Covid-19 vaccines, as well as provide products and services for biopharmaceutical manufacturing...
HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine. Under the agreement, HALIX will provide commercial manufacturing of drug substance at its state-of-the-art cGMP facility at the Leiden Bio Science Park in the Netherlands. To meet the increased demand, HALIX expands with two additional viral vector production lines....
Alpha Laboratories Ltd. (Eastleigh, UK) and shuttlepac Ltd. (Telford, UK) are delighted to announce that they have established an exclusive distribution partnership, in the UK and Ireland, that will bring new developments in UN3373 sample packaging solutions. Alpha Laboratories’ expertise in UN3373 compliance has, over many years, supported users in the healthcare and diagnostics arena, to develop compliant packaging systems for the transport of clinical samples from patient to laboratory....
Scientific Laboratory Supplies (SLS) and leading international life sciences company Eppendorf have been chosen to provide ultra-low temperature (ULT) freezers for the country’s supply of COVID-19 vaccines. SLS – the UK's largest independent supplier of chemicals, laboratory equipment and consumables – was awarded a contract by the Department of Health and Social Care (DHSC) to equip two central storage sites and 54 regional hubs with the vital laboratory equipment required for safe and secure storage of the newly developed vaccine....
Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts. Within the framework of their Northern Ireland Coronavirus Antibody Development Alliance (NICADA), the two organisations will use the funds to accelerate the discovery...
PerkinElmer, Inc., announce that the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government’s NHS Test and Trace program. The facility, operated by PerkinElmer Genomics, began processing samples and with its team of 400 scientists, researchers, technicians and operations personnel, has the capacity to test up to 50,000 samples daily by early 2021....
A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business with them. The concept was to create a central place for biotech SMEs to find academic labs through the content of available websites and scientific literature the labs have produced, as well as to keep an eye on the new labs, gain lead generation....
Scientists will soon have access to a powerful 1 GHz magnetic field to analyse the structure and dynamics with atomic resolution for a wide variety of systems across chemistry, and life and materials science in the UK for the first time, as a new high-powered magnet for Nuclear Magnetic Resonance (NMR) in the UK has been successfully been energized at the University of Warwick....
The Organisers of ARABLAB+ 2021 have rescheduled the exhibition dates to now take place on 15 - 17 NOVEMBER 2021. Dubai does provide a very safe and secure venue for the Exhibition. However, the current travel restrictions applying to many countries from which exhibitors and visitors originate, are preventing many participants from making their travel plans...
Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce that the Swansea University Medical School plans a clinical trial with Iota-/kappa-carrageenan nasal spray as a COVID-19 Prophylaxis for Healthcare Professionals (ICE-COVID). The investigator-initiated trial at Swansea will be recruiting 480 healthcare professionals managing COVID-19 patients during the pandemic....
Through an innovative sterilization & freeze-drying processes R&D laboratory, Telstar offers pharmaceutical companies located in China a qualified and complete consultancy service for the development, qualification and validation of process cycles, simplifying the assessment of a product's behaviour before the freeze drying or sterilization process, as well as adapting and optimizing the process before its industrial implementation....
Cancer researchers fear advances for patients could be delayed by almost a year and a half because of the effects of the Covid-19 pandemic, a new survey reveals. Scientists at The Institute of Cancer Research, London, told the survey that their own research advances would be pushed back by an average of six months by the initial lockdown, subsequent restrictions on laboratory capacity and the closure of national scientific facilities....
Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020. Dr Price was instrumental in setting up the Alderley Park Lighthouse Lab, which forms part of the largest diagnostic testing facility in British history, to help in the fight against Coronavirus.
Avacta Group plc, the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce significant progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions, and that the lateral flow test has very good analytical sensitivity with laboratory samples...
Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (HPIMS) / mass spectrometry (MS), has won The Analytical Scientist Innovation Award (TASIA) 2020. TASIAs showcase the technologies driving progress in measurement science. The award recognizes that HPIMS brings the power of state-of-the-art Ion Mobility out of the lab: enabling high resolution and sensitive chemical detection at the point of need...
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability, announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility. VMIC plans to implement the MODA-EM™ Solution as part of its strategy to develop a state-of-the-art manufacturing center due to open in 2021 – fast-tracked to open a year ahead of schedule...
LAUDA DR. R. WOBSER GMBH & CO. KG has once again been declared World Market Leader Champion in the field of "Constant Temperature Equipment and Systems for Precise Temperature Generation". This is the fifth award in a row for LAUDA. The family-owned company has been represented in the World Market Leader Index since the survey first started. The well-respected index has been drawn up under the direction of Prof. Dr. Christoph Müller from the University of St. Gallen since 2015....
Abbott has received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test. IgG antibody testing that gives a quantitative result (measuring the amount of antibodies) provides important insights to people as they recover from COVID-19 and help evaluate a person's immune response to a vaccine. Countries around the world are preparing for the authorisation and the distribution of COVID-19 vaccines....
Illumina, Inc. and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced by many families, with the goal of improving patient outcomes....
A new technology promoted by Telstar provides the interior of the cabinet with a high antimicrobial power and reduces cleaning and maintenance costs. A new photocatalytic treatment based on titanium dioxide has been implemented by Telstar inside their biological safety cabinets, designed to operate with risk 1, 2 and 3 biological agents (viruses and bacteria or infectious material). Zerocoat is the new treatment that provides a self-cleaning surface which breaks down organic matter when the light system is triggered....
ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy. Both companies have a long-standing collaboration and strategic partnership, as arivis has been an important development partner for ZEISS for more than seven years..
Agilent Technologies Inc. has announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North West....
Merck, a leading science and technology company, has announced the broadening of its manufacturing footprint with a combined €40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to customers developing lifesaving therapies, including Covid-19 vaccines, as well as provide products and services for biopharmaceutical manufacturing...
HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine. Under the agreement, HALIX will provide commercial manufacturing of drug substance at its state-of-the-art cGMP facility at the Leiden Bio Science Park in the Netherlands. To meet the increased demand, HALIX expands with two additional viral vector production lines....
Alpha Laboratories Ltd. (Eastleigh, UK) and shuttlepac Ltd. (Telford, UK) are delighted to announce that they have established an exclusive distribution partnership, in the UK and Ireland, that will bring new developments in UN3373 sample packaging solutions. Alpha Laboratories’ expertise in UN3373 compliance has, over many years, supported users in the healthcare and diagnostics arena, to develop compliant packaging systems for the transport of clinical samples from patient to laboratory....
Scientific Laboratory Supplies (SLS) and leading international life sciences company Eppendorf have been chosen to provide ultra-low temperature (ULT) freezers for the country’s supply of COVID-19 vaccines. SLS – the UK's largest independent supplier of chemicals, laboratory equipment and consumables – was awarded a contract by the Department of Health and Social Care (DHSC) to equip two central storage sites and 54 regional hubs with the vital laboratory equipment required for safe and secure storage of the newly developed vaccine....
Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts. Within the framework of their Northern Ireland Coronavirus Antibody Development Alliance (NICADA), the two organisations will use the funds to accelerate the discovery...
PerkinElmer, Inc., announce that the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government’s NHS Test and Trace program. The facility, operated by PerkinElmer Genomics, began processing samples and with its team of 400 scientists, researchers, technicians and operations personnel, has the capacity to test up to 50,000 samples daily by early 2021....
A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business with them. The concept was to create a central place for biotech SMEs to find academic labs through the content of available websites and scientific literature the labs have produced, as well as to keep an eye on the new labs, gain lead generation....
Scientists will soon have access to a powerful 1 GHz magnetic field to analyse the structure and dynamics with atomic resolution for a wide variety of systems across chemistry, and life and materials science in the UK for the first time, as a new high-powered magnet for Nuclear Magnetic Resonance (NMR) in the UK has been successfully been energized at the University of Warwick....
The Organisers of ARABLAB+ 2021 have rescheduled the exhibition dates to now take place on 15 - 17 NOVEMBER 2021. Dubai does provide a very safe and secure venue for the Exhibition. However, the current travel restrictions applying to many countries from which exhibitors and visitors originate, are preventing many participants from making their travel plans...
Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce that the Swansea University Medical School plans a clinical trial with Iota-/kappa-carrageenan nasal spray as a COVID-19 Prophylaxis for Healthcare Professionals (ICE-COVID). The investigator-initiated trial at Swansea will be recruiting 480 healthcare professionals managing COVID-19 patients during the pandemic....
Through an innovative sterilization & freeze-drying processes R&D laboratory, Telstar offers pharmaceutical companies located in China a qualified and complete consultancy service for the development, qualification and validation of process cycles, simplifying the assessment of a product's behaviour before the freeze drying or sterilization process, as well as adapting and optimizing the process before its industrial implementation....
Cancer researchers fear advances for patients could be delayed by almost a year and a half because of the effects of the Covid-19 pandemic, a new survey reveals. Scientists at The Institute of Cancer Research, London, told the survey that their own research advances would be pushed back by an average of six months by the initial lockdown, subsequent restrictions on laboratory capacity and the closure of national scientific facilities....
Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020. Dr Price was instrumental in setting up the Alderley Park Lighthouse Lab, which forms part of the largest diagnostic testing facility in British history, to help in the fight against Coronavirus.
Avacta Group plc, the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce significant progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions, and that the lateral flow test has very good analytical sensitivity with laboratory samples...